Tonix Pharmaceuticals Announces Publication of Paper on Antiviral SARS-CoV-2 Inhibitor, TNX-3500, in JCI Insight

NEXT STORY
23andMe Announces Redemption of All Outstanding Warrants
PREV STORY
Aptose to Present at the Piper Sandler 33rd Annual Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Positive Interim Results of CHOICE-01 Study Evaluating Coherus’ and Junshi Biosciences’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer

author_avatar
NASDAQ Market News

Datametrex Reports Government Clearance To Fulfill Its First COVID-19 Test Kit Order

author_avatar
NASDAQ Market News

PDS Biotechnology to Present at the 12th Annual LD Micro Main Event

author_avatar
NASDAQ Market News